A population-based study of transdermal fentanyl initiation in Australian clinical practice

[1]  T. Dobbins,et al.  To what extent do data from pharmaceutical claims under‐estimate opioid analgesic utilisation in Australia? , 2018, Pharmacoepidemiology and drug safety.

[2]  W. Hall,et al.  Trends in heroin and pharmaceutical opioid overdose deaths in Australia. , 2017, Drug and alcohol dependence.

[3]  R. Bruno,et al.  A nationwide study of the extent and factors associated with fentanyl use in Australia , 2017, Research in social & administrative pharmacy : RSAP.

[4]  S. Schug,et al.  Fentanyl Formulations in the Management of Pain: An Update , 2017, Drugs.

[5]  G. Guyatt,et al.  Attitudes toward the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain: A qualitative study. , 2016, Journal of opioid management.

[6]  T. Dobbins,et al.  Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated. , 2016, British journal of clinical pharmacology.

[7]  J. Gurwitz,et al.  New Initiation of Long‐Acting Opioids in Long‐Stay Nursing Home Residents , 2016, Journal of the American Geriatrics Society.

[8]  Madison,et al.  U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. , 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[9]  Sallie-Anne Pearson,et al.  Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims. , 2016, British journal of clinical pharmacology.

[10]  D. Currow,et al.  Using opioids in general practice for chronic non‐cancer pain: an overview of current evidence , 2016, The Medical journal of Australia.

[11]  S. Bugden,et al.  Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches , 2016, Canadian Medical Association Journal.

[12]  J. Kahn,et al.  Are Physicians Safely Prescribing Opioids for Chronic Noncancer Pain? A Systematic Review of Current Evidence , 2016, Pain practice : the official journal of World Institute of Pain.

[13]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[14]  S. Pearson,et al.  The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers , 2015, BMC Research Notes.

[15]  Lisa G. Pont,et al.  Safety of opioid patch initiation in Australian residential aged care , 2015, The Medical journal of Australia.

[16]  W. Hall,et al.  The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain , 2015, Pain.

[17]  N. Gisev,et al.  The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia , 2015, BMJ Open.

[18]  M. Kunz,et al.  Pain management in patients with dementia , 2013, Clinical interventions in aging.

[19]  E. Garbe,et al.  Utilisation of transdermal fentanyl in Germany from 2004 to 2006 , 2012, Pharmacoepidemiology and Drug Safety.

[20]  R. Sabatowski,et al.  Utilisation of transdermal fentanyl in Germany from 2004–2006 by Edeltraut Garbe and colleagues , 2012, Pharmacoepidemiology and drug safety.

[21]  E. Garbe,et al.  Utilisation of transdermal fentanyl in Germany from 2004 to 2006 , 2012, Pharmacoepidemiology and drug safety.

[22]  Christine Y. Lu,et al.  Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting. , 2011, Journal of clinical epidemiology.

[23]  V. Mor,et al.  Frequency of long-acting opioid analgesic initiation in opioid-naïve nursing home residents. , 2009, Journal of pain and symptom management.

[24]  A. Dahan,et al.  Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone) , 2008, Pain practice : the official journal of World Institute of Pain.

[25]  P. Slattum,et al.  Pharmacodynamics in older adults: a review. , 2007, The American journal of geriatric pharmacotherapy.

[26]  R. Herings,et al.  Utilisation pattern of fentanyl transdermal system in The Netherlands , 2005, Pharmacoepidemiology and drug safety.

[27]  F. Blyth,et al.  Chronic pain in Australia: a prevalence study , 2001, Pain.

[28]  Julie Byles,et al.  Health and Ageing , 2017 .

[29]  S. Hyland,et al.  Safety Issues with Fentanyl Patches Require Pharmaceutical Care , 2008 .